Position in JNJ
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$3,852,470
+$165,826 QoQ
Shares Held
15,169
+0.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.67%
of 13F equity value
Holder Rank
#1,802
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AdvisorNet Financial, Inc holds $20,577,968 across 14 Drug Manufacturers - General names. JNJ ranks #1 (18.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
15,169 | $3,852,470 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
27,109 | $3,424,951 | |
| 3 | LLY |
ELI LILLY & Co
|
2,556 | $3,065,743 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
38,342 | $2,209,266 | |
| 5 | AZN |
Astrazeneca PLC
|
11,574 | $2,194,661 | |
| 6 | ABBV |
AbbVie Inc.
|
6,595 | $1,659,565 | |
| 7 | MRK |
Merck & Co., Inc.
|
10,405 | $1,337,042 | |
| 8 | GSK |
GSK plc
|
17,988 | $942,930 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,852,470 | 15,169 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $3,686,644 | 15,082 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $3,170,887 | 15,322 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $2,691,742 | 14,517 | Shares | Sole | 2025-10-09 | |
| 2025-06-30 | $1,753,264 | 11,478 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $1,903,677 | 11,479 | Shares | Sole | 2025-04-07 | |
| 2024-12-31 | $1,607,740 | 11,117 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $2,031,908 | 12,538 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $1,768,389 | 12,099 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $1,924,855 | 12,168 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $2,276,335 | 14,523 | Shares | Sole | 2024-01-19 | |
| 2023-09-30 | $3,960,255 | 25,427 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $4,605,428 | 27,824 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $4,346,665 | 28,043 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $4,868,297 | 27,559 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $4,711,955 | 28,844 | Shares | Sole | 2022-10-04 | |
| 2022-06-30 | $5,074,478 | 28,587 | Shares | Sole | 2022-07-07 | |
| 2022-03-31 | $5,116,630 | 28,870 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $4,852,229 | 28,364 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $5,033,632 | 31,168 | Shares | Sole | 2021-10-15 | |
| 2021-06-30 | $7,671,777 | 46,569 | Shares | Sole | 2021-07-06 | |
| 2021-03-31 | $7,776,220 | 47,315 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $7,251,598 | 46,077 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $7,153,237 | 48,047 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $6,818,586 | 48,486 | Shares | Sole | 2020-08-26 | |
| 2020-03-31 | $6,888,258 | 52,530 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||